Accession Number: | 0001209191-14-071564 |
Date: | 2014-11-24 |
Issuer: | NEKTAR THERAPEUTICS (NKTR) |
Original Submission Date: |
LINGNAU LUTZ
C/O NEKTAR THERAPEUTICS
455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO, CA 94158
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2014-11-24 | M | 15,000 | a | $8.81 | 31,450 | direct | ||
COMMON STOCK | 2014-11-24 | S | 15,000 | d | $15.02 | 16,450 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION | 8.81 | 2014-11-24 | deemed execution date | M | 15,000 (d) | 2008-09-19 | 2015-09-18 | common stock 15,000 | $8.81 | 0 | direct |
ID | footnote |
---|---|
f1 | this transaction was made pursuant to a rule 10b5-1 trading plan adopted by the reporting person. |
f2 | this transaction was executed in multiple trades at prices ranging from $15.00 to $15.36. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the sec staff, the issuer, or a security holder of the issuer. |